NORMAL SITUATION

FINANCIERE DU LOUVY

Export PDF

Company — Normal situation.

Financial year 2024 · Closed on 31/12/2024

Net result-6,3 k €-393,8 %over 1 year
Gross margin-2,1 k €-130,7 %over 1 year
Equity467,1 k €-1,3 %over 1 year

Identity

Source · BCE/KBO

FINANCIERE DU LOUVY is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0450.455.924
Legal form
Public limited company
Contributed capital
128 905,00 €
Latest accounts
31/12/2024
Signals
Solid equity

Financials

Source · NBB, 31 filings

Trend over 18 financial years

20242023202220212020
Income statement
Gross margin-2,1 k €6,9 k €24,6 k €17,4 k €15,8 k €
EBITDA-5 k €4,2 k €24,6 k €14,8 k €13,8 k €
Operating result-6,1 k €3 k €18 k €14 k €13,1 k €
Net result-6,3 k €2,1 k €113,2 k €159,4 k €9,1 k €
Balance sheet
Equity467,1 k €473,4 k €471,3 k €358,1 k €198,7 k €
Total assets467,1 k €473,4 k €471,3 k €359,6 k €199,6 k €
Cash320,8 k €325,4 k €324,4 k €211 k €54,8 k €
Debts–––1,5 k €870 €

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 9 ended

Active mandates

FINPHARMA SA

Director · since 18 mars 2022 · until 17 mars 2028

Represented by PHILIPPE BOULANGER

Active
GESTIPHARMA

Managing director · since 18 mars 2022 · until 17 mars 2028 · 0425.530.684

Represented by PIERRE -PASCAL HECQ

Active

Ended mandates

FINPHARMA SA

Director · since 26 novembre 2021 · until 26 novembre 2027

Represented by PHILIPPE BOULANGER

Ended
GESTIPHARMA

Managing director · since 26 novembre 2021 · until 26 novembre 2027 · 0425.530.684

Represented by PIERRE HECQ

Ended
PIERRE HECQ

Managing director · since 27 novembre 2015 · until 26 novembre 2021

Ended
UNIVERSAL PHARMA

Director · since 27 novembre 2015 · until 26 novembre 2021 · 0447.382.113

Represented by PIERRE HECQ

Ended

Full financial information

Source · NBB
202420232022202120202019
Type of accountMicro modelMicro modelMicro modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/07/202101/07/202001/07/201901/07/2018
Closing of the financial year31/12/202431/12/202331/12/202230/06/202130/06/202030/06/2019
Length of the financial year12 months12 months18 months12 months12 months12 months
Filing date14/07/202506/08/202423/08/202314/12/202109/12/202016/12/2019
General meeting27/06/202528/06/202430/06/202326/11/202127/11/202029/11/2019
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 31 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202427/06/202514/07/2025FrenchPDF
Micro model31/12/202328/06/202406/08/2024FrenchPDF
Micro model31/12/202230/06/202323/08/2023FrenchPDF
Abridged model30/06/202126/11/202114/12/2021FrenchPDF
Abridged model30/06/202027/11/202009/12/2020FrenchPDF
Abridged model30/06/201929/11/201916/12/2019FrenchPDF
Abridged model30/06/201830/11/201810/12/2018FrenchPDF
Abridged model30/06/201724/11/201720/12/2017FrenchPDF
Abridged model30/06/201625/11/201606/12/2016FrenchPDF
Abridged model30/06/201527/11/201509/12/2015FrenchPDF
Abridged model30/06/201428/11/201416/12/2014FrenchPDF
Abridged model30/06/201329/11/201311/12/2013FrenchPDF
Abridged model30/06/201230/11/201229/01/2013FrenchPDF
Abridged model30/06/201125/11/201120/01/2012FrenchPDF
Abridged model30/06/201028/11/201006/12/2010FrenchPDF
Abridged model30/06/200927/11/200911/01/2010FrenchPDF
Abridged model30/06/200828/11/200810/12/2008FrenchPDF
Abridged model30/06/200723/11/200704/12/2007FrenchPDF
Abridged model30/06/200624/11/200615/12/2006FrenchPDF
Abridged model30/06/200525/11/200518/01/2006FrenchPDF
Abridged model30/06/200426/11/200428/12/2004FrenchPDF
Abridged model30/06/200328/11/200330/12/2003FrenchPDF
Abridged model30/06/200229/11/200229/11/2002FrenchPDF
Abridged model30/06/200125/01/200222/02/2002FrenchPDF

View all 31 filings

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 9 ended

Active mandates

FINPHARMA SA

Director · since 18 mars 2022 · until 17 mars 2028

Represented by PHILIPPE BOULANGER

Active
GESTIPHARMA

Managing director · since 18 mars 2022 · until 17 mars 2028 · 0425.530.684

Represented by PIERRE -PASCAL HECQ

Active

Ended mandates

FINPHARMA SA

Director · since 26 novembre 2021 · until 26 novembre 2027

Represented by PHILIPPE BOULANGER

Ended
GESTIPHARMA

Managing director · since 26 novembre 2021 · until 26 novembre 2027 · 0425.530.684

Represented by PIERRE HECQ

Ended
PIERRE HECQ

Managing director · since 27 novembre 2015 · until 26 novembre 2021

Ended
UNIVERSAL PHARMA

Director · since 27 novembre 2015 · until 26 novembre 2021 · 0447.382.113

Represented by PIERRE HECQ

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution19/01/2026
    RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
    PDF
  • Mandates09/12/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates10/05/2022
    DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - ANNEE COMPTABLE - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates08/03/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates06/01/2016
    DEMISSIONS, NOMINATIONS
    PDF
  • Other27/12/2013
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates21/02/2012
    DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates14/01/2011
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024-6,3 k €↓
  2. 2023
    Annual accounts 20232,1 k €↓
  3. 2022
    Annual accounts 2022113,2 k €↓
  4. 2021
    Annual accounts 2021159,4 k €↑
  5. 2020
    Annual accounts 20209,1 k €↓
  6. 2019
    Annual accounts 201910 k €↑
  7. 2018
    Annual accounts 20189 k €↓
  8. 2017
    Annual accounts 20179,4 k €↑
  9. 2016
    Annual accounts 20169,2 k €↓
  10. 2015
    Annual accounts 20159,9 k €↓
  11. 2014
    Annual accounts 201429,6 k €↑
  12. 2013
    Annual accounts 2013-742 €↑
  13. 2012
    Annual accounts 2012-14,3 k €↓
  14. 2011
    Annual accounts 20116,1 k €↓
  15. 2010
    Annual accounts 20107 k €↑
  16. 2009
    Annual accounts 20094,7 k €↑
  17. 2008
    Annual accounts 20083,7 k €↑
  18. 2007
    Annual accounts 20073,1 k €